Glycosaminoglycan
Derived
Disaccharides |
| HEPARIN/HEPARAN
SERIES - Disaccharides
 |
| Catalog Number |
Product Name |
|
Pack Size |
| H1001 |
DUA-2S GlcNS-6S
Na4 (disaccharide I-S)
Predominant disaccharide produced from heparin
by heparinases I and II.
C12H15NO19S3Na4 · FW
665.37
|
|
1 mg
5
mg
25 mg |
| H1002 |
DUA GlcNS-6S
Na3 (disaccharide II-S)
Produced from heparinase II digestion of heparin
and heparan sulphate.
C12H16NO16S2Na3· FW
563.34
|
|
0.5 mg
2 mg
|
| H1003 |
DUA-2S GlcNS
Na3 (disaccharide III-S)
Produced from heparin by digestion with heparinases
I and II.
C12 H16 NO16 S2 Na3 · FW
563.34
|
|
1 mg
2
mg
|
| H1005 |
DUA-2S GlcNAc-6S
Na3 (disaccharide I-A)
Minor component produced from heparin by
heparinase II.
C14H1 NO1 S Na3 · FW
605.38
|
|
1 mg
2
mg
5 mg |
| H1006 |
DUA GlcNAc-6S Na2 (disaccharide II-A)
Product of the action of heparinases II and III on
heparin
and heparan sulphate.
C14H19NO14SNa2 · FW 503.34
|
|
1 mg
5 mg |
| H1007 |
DUA-2S GlcNAc
Na2 (disaccharide III-A)
Minor product of the action of heparinase II on
heparin.
C14H19NO14SNa2 · FW 503.34
|
|
1 mg
5 mg |
| H1008 |
DUA GlcNAc Na (disaccharide IV-A)
Produced from heparan sulphate by digestion with
heparinase III.
C14H20 NO11Na · FW 401.30
|
|
0.5 mg
5 mg |
| H1009 |
ΔUA-2S GlcN-6S Na-salt. Heparin unsaturated disaccharide I-H
Disaccharide IH is the major component from the action of heparinase II on de-N-sulphated heparin.
Ref: Moffat, CF et al (1985) Proc 8th Int. Symp. Glycoconjugates 1, 79.
C12H17NO16S2Na2 FW 541.36
|
|
1 mg
2 mg |
| H1010 |
ΔUA GlcN-6S Na-salt. Heparin unsaturated disaccharide II-H
Disaccharide IIH is the major component from the action of heparinase II on de-N-sulphated heparin.
Ref: Moffat, CF et al (1985) Proc 8th Int. Symp. Glycoconjugates 1, 79.
C12H18NO13SNa FW 439.32
|
|
1 mg
2 mg |
| H1011 |
ΔUA 2S GlcN Na-salt. Heparin unsaturated disaccharide III-H
Disaccharide IIIH is the major component from the action of heparinase II on de-N-sulphated heparin.
Ref: Moffat, CF et al (1985) Proc 8th Int. Symp. Glycoconjugates 1, 79.
C12H18NO13SNa FW 439.32
|
|
1 mg
2 mg |
| H1012 |
ΔUA GlcN Free acid, zwitterion. Heparin unsaturated disaccharide IV-H
Disaccharide IVH is obtained from the action of heparinases on heparin.
C12H19NO10 FW 337.28
|
|
1 mg
2 mg |
| H1013 |
ΔUA-2S GlcNCOEt-6S Na-salt. Heparin unsaturated disaccharide I-P
Disaccharide I-P is obtained by N-propionylation of heparin unsaturated disaccharide I-H. It is a homologue of disaccharide I-A with the inclusion of a methylene group in the amide acyl group. It does not occur in nature and was devised as an internal standard for HPLC, CZE and CE analysis of heparin/heparin sulphate. It can also ideal as an internal standard for HLPC/CZE analysis of chondroitin series using chondroitinases.
C15H20NO17S2Na3 FW 619.4
|
|
1 mg
2 mg |
| CHONDROITIN SERIES
 |
| C3201 |
DUA
GalNAc (D Di-OS)
Produced from various chondroitin sulphates
by the
action of
chondroitinases ABC, AC-1 and C.
C14H20NO11Na · FW 401.30
|
|
5 mg
10 mg |
| C3202 |
DUA
GalNAc-4S (D Di-4S)
Produced from various chondroitin sulphates by
the
action of
chondroitinases ABC, B and AC-1.
C14H19NO14SNa2 · FW 503.34
|
|
5 mg
10 mg |
| C3203 |
DUA
GalNAc-6S (D Di-6S)
Produced from various chondroitin sulphates by
the
action of
chondroitinases ABC, AC-1 and C.
C14H19NO14SNa2 · FW 503.34
|
|
5 mg
10
mg
25 mg |
| C3204 |
DUA
GalNAc-4S, 6S (D Di-disE)
Produced from various chondroitin sulphates by
the
action of
chondroitinases ABC, B and/or AC-1.
C14H18NO17S2Na3 · FW
605.38
|
|
1 mg
5 mg |
| C3205 |
DUA-2S
GalNAc-4S (D Di-disB)
Produced from various chondroitin sulphates by action
of chondroitinase
ABC and/or B. Most typically from chondroitin sulphate B (dermatan sulphate).
C14H18NO17S2Na3 · FW
605.38
|
|
1 mg
5 mg |
| C3206 |
DUA-2S
GalNAc- 6S (D Di-disD)
Produced from various chondroitin sulphates by action
of
chondroitinase ABC.
C14H18NO17S2Na3 · FW
605.38
|
|
1 mg
5 mg |
| C3207 |
DUA-2S
GalNAc-4S- 6S (D Di-triS)
Produced as a minor component by the action of
chondroitinase ABC
on various chondroitin sulphates, particularly B.
C14H17NO20S3Na4 · FW
707.42
|
|
1 mg
5 mg |
| C3208 |
DUA-2S
GalNAc (D Di-UA2S)
Produced as a minor component from various chondroitin
sulphates
by the action of chondroitinase ABC.
C14H19NO14SNa2 · FW 503.34
|
|
1
mg
5 mg |
| HYALURONIC ACID SERIES
|
| C3209 |
DUA GlcNAc (D Di-HA)
The only unsaturated disaccharide produced from
hyaluronic acid by the action of chondroitinases ABC or AC-1.
C14H20NO11Na · FW
401.30
|
|
2 mg
5 mg |
| CHONDROITIN SATURATED
DISACCHARIDES
 |
| C4202 |
GlcA GalNAc-4S (Di-4S)
The disaccharide repeat of chondroitin sulphate A
(chondroitin 4-sulphate).
C14H21NO15SNa2 · FW 521.36
|
|
1 mg
2 mg |
| C4203 |
GlcA GalNAc-6S (Di-6S)
The disaccharide repeat of chondroitin sulphate C
(chondroitin 6-sulphate).
C14H21NO15SNa2 · FW 521.36
|
|
1 mg
2 mg |
